Procurement Summary
Country : Germany
Summary : Contract notice: Pharmaceutical products
Deadline : 05 Jul 2019
Other Information
Notice Type : Tender
TOT Ref.No.: 15062478
Document Ref. No. : 282779-2017
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NOVITAS BKK
Office Name: Novitas BKK
Town: Duisburg
Contact Point: spectrumK GmbH
Germany
Email :open-house@spectrumk.de
URL :www.spectrumk.de
Tender Details
Object of the contract
Pharmaceutical products
Description: Contract notice: Pharmaceutical products
Authority Type: Other
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.
Completion of a non-exclusive discount agreement pursuant to section 130a para. 8 SGB V on tenofovir disoproxil and emtricitabine, ATC code: J05AR03, for the period from 1 January 2017 to 31 August 2019
This announcement is the end Of drug discounts pursuant to section 130a (8) SGB V concerning the combination of active substances mentioned in point II.1.1. It is aboutDoes not concern the award of public contracts within the meaning of Directive 2014/24 / EU or -- 97 ff GWB. The contracting party may be any pharmaceutical contractor in accordance with section 4 (18) AMG. According to the jurisprudence of the European Court of Justice, such authorization procedures are not necessarily subject to the granting of authorization, since no competition takes place due to the lack of a selection decision. The notice serves-As a request for the conclusion of discount agreements with conditions valid for all contractual partners and non-disposable conditions, including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required explanations, which can be requested from the contact point named under I.3).
Early start of the contract-Of 01.09.2017 provided that the signed contract and the required declarations have been received by 11.3.2017 at the contact point named under I.3). This is referred to in IV.2.2). In the case of subsequent receipt of the contract, the first day of the month commencing on the month of the receipt of the signed contract as well as the required declarations and / or proofs at theI.3), provided that the receipt is made up to the 5th of a month in each case; Otherwise the 1 st of the next month. The contracts automatically terminate without the need for any notification as soon as the active substance (s) or combination of drugs (s) are concluded in the course of an award procedure. The contracts end with 31.8.2019(A) Declaration of assurance,
b) Register of commercial registers (not more than 3 months from the start of the contract period).
Foreign bidders must provide equivalent certificates of their home country.
A contract is concluded only if all required proofs and certifi- catesFor the purpose of better comparability and the enhancement of clarity, the required information shall be summarized in the form of prescribed forms, which shall be used, signed and, together with the supporting documents and declarations required therein, together with the contract documents . Information and formalities which may be requiredAre required to verify compliance with the requirements:
- Declaration of eligibility.
A contract shall be concluded only if all required documents and certificates are available at the contact point indicated in I.3).
For better comparability and for clarity The required information is summarized in a given form, Which should be used, signed and submitted together with the supporting documents and declarations required therein with the contract documents
Internet address (URL): www.spectrumk.de
Directive: Classical Directive (2014/24/EU)
Documents
Tender Notice